GENERIC AVAILABLE: Yes
PREPARATIONS: Solution for injection into the knee joint (intra-articular injection): 10 mg/ml or 15 mg/ml
STORAGE: Sodium hyaluronate should be stored in the original packaging below 25 C (77 F). It should be protected from light.
DOSING: Sodium hyaluronate is administered into the knee joint (intra-articular injection) once a week for a total of 3-5 injections. 20 mg (Euflexxa, Hyalgan) or 25 mg (Supartz) should be injected into the affected knee once weekly.
DRUG INTERACTIONS: No clinically significant drug-drug interactions between sodium hyaluronate injection and other medications have been reported.
PREGNANCY: It is not known whether sodium hyaluronate is safe to use during pregnancy because it has not been evaluated in pregnant women.
NURSING MOTHERS: It is not known if sodium hyaluronate can enter human milk. The safety and effectiveness of sodium hyaluronate has not been established in nursing mothers.
REFERENCE: FDA Prescribing Information
Quick GuideOsteoarthritis (OA): Treatment, Symptoms, Diagnosis
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.